{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:44:53Z","timestamp":1793130293714,"version":"4.5.0"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11011-020-00648-6","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T10:08:55Z","timestamp":1609927735000},"page":"375-406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis"],"prefix":"10.1007","volume":"36","author":[{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Honarmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"648_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3109\/08820139.2013.812652","volume":"42","author":"S Almasi","year":"2013","unstructured":"Almasi S, Aliparasti MR, Farhoudi M, Babaloo Z, Baradaran B, Zamani F, Sadeghi-Bazargani H, Mostafaei S, Hokmabadi ES (2013) Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis. Immunological investigations 42:737\u2013748","journal-title":"Immunological investigations"},{"key":"648_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/1352458512473362","volume":"19","author":"E Alvarez","year":"2013","unstructured":"Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT, Cross AH (2013) CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions. Multiple Sclerosis Journal 19:1204\u20131208","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/glia.22794","volume":"63","author":"S Anastasiadou","year":"2015","unstructured":"Anastasiadou S, Liebenehm S, Sinske D, Meyer Zu Reckendorf C, Moepps B, Nordheim A, Kn\u00f6ll B (2015) Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model. Glia 63:958\u2013976","journal-title":"Glia"},{"key":"648_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneuroim.2006.08.012","volume":"181","author":"AS Archambault","year":"2006","unstructured":"Archambault AS, Sim J, Mccandless EE, Klein RS, Russell JH (2006) Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. Journal of neuroimmunology 181:122\u2013132","journal-title":"Journal of neuroimmunology"},{"key":"648_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2012.01.022","volume":"148","author":"Y Arima","year":"2012","unstructured":"Arima Y, Harada M, Kamimura D, Park J-H, Kawano F, Yull FE, Kawamoto T, Iwakura Y, Betz UA, M\u00e1rquez G (2012) Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148:447\u2013457","journal-title":"Cell"},{"key":"648_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1352458513490544","volume":"20","author":"M Axelsson","year":"2014","unstructured":"Axelsson M, Malmestr\u00f6m C, Gunnarsson M, Zetterberg H, Sundstr\u00f6m P, Lycke J, Svenningsson A (2014) Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis. Multiple Sclerosis Journal 20:43\u201350","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2013.09.003","volume":"264","author":"M Axelsson","year":"2013","unstructured":"Axelsson M, Mattsson N, Malmestr\u00f6m C, Zetterberg H, Lycke J (2013) The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis. Journal of neuroimmunology 264:100\u2013105","journal-title":"Journal of neuroimmunology"},{"key":"648_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","volume":"47","author":"H Azin","year":"2012","unstructured":"Azin H, Vazirinejad R, Ahmadabadi BN, Khorramdelazad H, Zarandi ER, Arababadi MK, Karimabad MN, Shamsizadeh A, Rafatpanah H, Hassanshahi G (2012) The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. Journal of Molecular Neuroscience 47:431\u2013436","journal-title":"Journal of Molecular Neuroscience"},{"key":"648_CR9","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1523\/JNEUROSCI.23-21-07922.2003","volume":"23","author":"AA Babcock","year":"2003","unstructured":"Babcock AA, Kuziel WA, Rivest S, Owens T (2003) Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. Journal of Neuroscience 23:7922\u20137930","journal-title":"Journal of Neuroscience"},{"key":"648_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1468-1331.2004.00951.x","volume":"12","author":"H Bartosik-Psujek","year":"2005","unstructured":"Bartosik-Psujek H, Stelmasiak Z (2005) The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease. Eur J Neurol 12:49\u201354","journal-title":"Eur J Neurol"},{"key":"648_CR11","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1007\/s00415-018-8994-5","volume":"265","author":"MS Bassi","year":"2018","unstructured":"Bassi MS, Iezzi E, Landi D, Monteleone F, Gilio L, Simonelli I, Musella A, Mandolesi G, De Vito F, Furlan R (2018) Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. Journal of neurology 265:2540\u20132547","journal-title":"Journal of neurology"},{"key":"648_CR12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1172\/JCI33464","volume":"118","author":"AS Basso","year":"2008","unstructured":"Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M (2008) Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. The Journal of clinical investigation 118:1532\u20131543","journal-title":"The Journal of clinical investigation"},{"key":"648_CR13","doi-asserted-by":"publisher","first-page":"L278","DOI":"10.1152\/ajplung.1994.266.3.L278","volume":"266","author":"S Becker","year":"1994","unstructured":"Becker S, Quay J, Koren HS, Haskill J (1994) Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. American Journal of Physiology-Lung Cellular and Molecular Physiology 266:L278\u2013L286","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"648_CR14","doi-asserted-by":"crossref","unstructured":"Bielekova B, Komori M, Xu Q, Reich DS, Wu T (2012) Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation. PloS one, 7","DOI":"10.1371\/journal.pone.0048370"},{"key":"648_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.imbio.2015.01.007","volume":"220","author":"J Bla\u017eevskI","year":"2015","unstructured":"Bla\u017eevskI J, petkovi\u0107 F, Mom\u010dilovi\u0107 M, Jevti\u0107 B, Stojkovi\u0107 MM, Miljkovi\u0107 D (2015) Tumor necrosis factor stimulates expression of CXCL12 in astrocytes. Immunobiology 220:845\u2013850","journal-title":"Immunobiology"},{"key":"648_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s12272-013-0161-z","volume":"36","author":"S Bose","year":"2013","unstructured":"Bose S, Cho J (2013) Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Archives of pharmacal research 36:1039\u20131050","journal-title":"Archives of pharmacal research"},{"key":"648_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.psyneuen.2018.01.002","volume":"89","author":"P Brenner","year":"2018","unstructured":"Brenner P, Granqvist M, K\u00f6nigsson J, Al Nimer F, Piehl F, Jokinen J (2018) Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers. Psychoneuroendocrinology 89:53\u201358","journal-title":"Psychoneuroendocrinology"},{"key":"648_CR18","doi-asserted-by":"crossref","unstructured":"Brettschneider, J., Czerwoniak, A., Senel, M., Fang, L., Kassubek, J., Pinkhardt, E., Lauda, F., Kapfer, T., Jesse, S. & Lehmensiek, V. 2010. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PloS one, 5.","DOI":"10.1371\/journal.pone.0011986"},{"key":"648_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00401-014-1317-8","volume":"128","author":"M Bsibsi","year":"2014","unstructured":"Bsibsi M, Peferoen LA, Holtman IR, Nacken PJ, Gerritsen WH, Witte ME, Van Horssen J, Eggen BJ, Van Der Valk P, Amor S (2014) Demyelination during multiple sclerosis is associated with combined activation of microglia\/macrophages by IFN-\u03b3 and alpha B-crystallin. Acta neuropathologica 128:215\u2013229","journal-title":"Acta neuropathologica"},{"key":"648_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jneuroim.2014.10.005","volume":"277","author":"J Burman","year":"2014","unstructured":"Burman J, Svensson E, Fransson M, Loskog AS, Zetterberg H, Raininko R, Svenningsson A, Fagius J, Mangsbo SM (2014) The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1\/Th2\/Th17 convention. Journal of neuroimmunology 277:153\u2013159","journal-title":"Journal of neuroimmunology"},{"key":"648_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","volume":"48","author":"JP Buschmann","year":"2012","unstructured":"Buschmann JP, Berger K, Awad H, Clarner T, Beyer C, Kipp M (2012) Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. Journal of Molecular Neuroscience 48:66\u201376","journal-title":"Journal of Molecular Neuroscience"},{"key":"648_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jneuroim.2007.08.009","volume":"190","author":"M Buttmann","year":"2007","unstructured":"Buttmann M, Merzyn C, Hofstetter HH, Rieckmann P (2007) TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-\u03b2 treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response. Journal of neuroimmunology 190:170\u2013176","journal-title":"Journal of neuroimmunology"},{"key":"648_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2004.07.016","volume":"156","author":"M Buttmann","year":"2004","unstructured":"Buttmann M, Merzyn C, Rieckmann P (2004) Interferon-\u03b2 induces transient systemic IP-10\/CXCL10 chemokine release in patients with multiple sclerosis. Journal of neuroimmunology 156:195\u2013203","journal-title":"Journal of neuroimmunology"},{"key":"648_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ni735","volume":"2","author":"RS Bystry","year":"2001","unstructured":"Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nature immunology 2:1126\u20131132","journal-title":"Nature immunology"},{"key":"648_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2006.05.003","volume":"177","author":"TM Calderon","year":"2006","unstructured":"Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, RAINE CS, BERMAN JW (2006) A role for CXCL12 (SDF-1\u03b1) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. Journal of neuroimmunology 177:27\u201339","journal-title":"Journal of neuroimmunology"},{"key":"648_CR26","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.bbi.2010.01.011","volume":"24","author":"SJ Campbell","year":"2010","unstructured":"Campbell SJ, Meier U, Mardiguian S, Jiang Y, Littleton ET, Bristow A, Relton J, Connor TJ, Anthony DC (2010) Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain, behavior, and immunity 24:738\u2013746","journal-title":"Brain, behavior, and immunity"},{"key":"648_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.imlet.2013.12.020","volume":"158","author":"C Camperio","year":"2014","unstructured":"Camperio C, Muscolini M, Volpe E, Di Mitri D, Mechelli R, Buscarinu MC, Ruggieri S, Piccolella E, Salvetti M, Gasperini C (2014) CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes. Immunology letters 158:134\u2013142","journal-title":"Immunology letters"},{"key":"648_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2014.07.004","volume":"55","author":"O Cedile","year":"2014","unstructured":"Cedile O, L\u00f8bner M, Toft-Hansen H, Frank I, Wlodarczyk A, IRLA M, Owens T (2014) Thymic CCL2 influences induction of T-cell tolerance. Journal of autoimmunity 55:73\u201385","journal-title":"Journal of autoimmunity"},{"key":"648_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep45284","volume":"7","author":"C Cerutti","year":"2017","unstructured":"Cerutti C, Edwards LJ, De Vries HE, Sharrack B, Male DK, Romero IA (2017) MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium. Scientific reports 7:1\u201314","journal-title":"Scientific reports"},{"key":"648_CR30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. New England Journal of Medicine 354:610\u2013621","journal-title":"New England Journal of Medicine"},{"key":"648_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1172\/JCI25308","volume":"116","author":"Y Chen","year":"2006","unstructured":"Chen Y, Langrish CL, Mckenzie B, Joyce-Shaikh B, Stumhofer JS, Mcclanahan T, Blumenschein W, Churakovsa T, Low J, Presta L (2006) Anti\u2013IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. The Journal of clinical investigation 116:1317\u20131326","journal-title":"The Journal of clinical investigation"},{"key":"648_CR32","doi-asserted-by":"crossref","unstructured":"Cheng W, Chen G (2014a) Chemokines and chemokine receptors in multiple sclerosis. Mediators of inflammation, 2014.","DOI":"10.1155\/2014\/659206"},{"key":"648_CR33","doi-asserted-by":"publisher","first-page":"659206","DOI":"10.1155\/2014\/659206","volume":"2014","author":"W Cheng","year":"2014","unstructured":"Cheng W, Chen G (2014b) Chemokines and chemokine receptors in multiple sclerosis. Mediators of inflammation 2014:659206\u2013659206","journal-title":"Mediators of inflammation"},{"key":"648_CR34","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0000000000000361","volume":"82","author":"JR Christensen","year":"2014","unstructured":"Christensen JR, Ratzer R, B\u00f6rnsen L, Lyksborg M, Garde E, Dyrby TB, Siebner HR, Sorensen PS, Sellebjerg F (2014) Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial. Neurology 82:1499\u20131507","journal-title":"Neurology"},{"key":"648_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0165-5728(02)00064-4","volume":"126","author":"M Comabella","year":"2002","unstructured":"Comabella M, Imitola J, Weiner HL, Khoury SJ (2002) Interferon-\u03b2 treatment alters peripheral blood monocytes chemokine production in MS patients. Journal of neuroimmunology 126:205\u2013212","journal-title":"Journal of neuroimmunology"},{"key":"648_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/rr52","volume":"2","author":"DM Conroy","year":"2001","unstructured":"Conroy DM, Williams TJ (2001) Eotaxin and the attraction of eosinophils to the asthmatic lung. Respiratory research 2:150","journal-title":"Respiratory research"},{"key":"648_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J","volume":"55","author":"AK Cross","year":"1999","unstructured":"Cross AK, Woodroofe MN (1999) Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. Journal of neuroscience research 55:17\u201323","journal-title":"Journal of neuroscience research"},{"key":"648_CR38","doi-asserted-by":"publisher","first-page":"35797","DOI":"10.1074\/jbc.M507959200","volume":"280","author":"NM Curran","year":"2005","unstructured":"Curran NM, Griffin BD, O'toole D, Brady KJ, Fitzgerald SN, Moynagh PN (2005) The synthetic cannabinoid R (+) WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner. Journal of Biological Chemistry 280:35797\u201335806","journal-title":"Journal of Biological Chemistry"},{"key":"648_CR39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1365-2990.2012.01279.x","volume":"39","author":"TG D'aversa","year":"2013","unstructured":"D'aversa TG, Eugenin EA, Lopez L, Berman JW (2013) Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood\u2013brain barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathology and applied neurobiology 39:270\u2013283","journal-title":"Neuropathology and applied neurobiology"},{"key":"648_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep22556","volume":"6","author":"DJ Daugherty","year":"2016","unstructured":"Daugherty DJ, Chechneva O, Mayrhofer F, Deng W (2016) The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis. Scientific reports 6:1\u20137","journal-title":"Scientific reports"},{"key":"648_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fimmu.2012.00188","volume":"3","author":"N Dixit","year":"2012","unstructured":"Dixit N, Simon SI (2012) Chemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrest. Frontiers in immunology 3:188\u2013188","journal-title":"Frontiers in immunology"},{"key":"648_CR42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.pharep.2018.05.008","volume":"70","author":"S Dolati","year":"2018","unstructured":"Dolati S, Ahmadi M, Aghebti-Maleki L, Nikmaram A, Marofi F, Rikhtegar R, Ayromlou H, Yousefi M (2018) Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacological Reports 70:1158\u20131167","journal-title":"Pharmacological Reports"},{"key":"648_CR43","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/glia.23058","volume":"64","author":"T Draheim","year":"2016","unstructured":"Draheim T, Liessem A, Scheld M, Wilms F, Weissflog M, Denecke B, Kensler TW, Zendedel A, Beyer C, Kipp M (2016) Activation of the astrocytic Nrf2\/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model. Glia 64:2219\u20132230","journal-title":"Glia"},{"key":"648_CR44","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","volume":"168","author":"JH Dufour","year":"2002","unstructured":"Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD (2002) IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. The Journal of Immunology 168:3195\u20133204","journal-title":"The Journal of Immunology"},{"key":"648_CR45","doi-asserted-by":"crossref","unstructured":"Eggers EL, Michel BA, Wu H, Wang S-Z, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E (2017) Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. JCI insight 2","DOI":"10.1172\/jci.insight.92724"},{"key":"648_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.gene.2018.11.006","volume":"685","author":"FZ El Sharkawi","year":"2019","unstructured":"El Sharkawi FZ, Ali SA, Hegazy MI, Atya HB (2019) The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt. Gene 685:164\u2013169","journal-title":"Gene"},{"key":"648_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jneuroim.2015.04.011","volume":"283","author":"D Ferraro","year":"2015","unstructured":"Ferraro D, Galli V, Vitetta F, Simone AM, Bedin R, Del Giovane C, Morselli F, Filippini MM, Nichelli PF, Sola P (2015) Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: association with oligoclonal IgM bands and prediction of multiple sclerosis diagnosis. Journal of neuroimmunology 283:64\u201369","journal-title":"Journal of neuroimmunology"},{"key":"648_CR48","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1177\/1352458509107017","volume":"15","author":"ED Festa","year":"2009","unstructured":"Festa ED, Hankiewicz K, Kim S, Skurnick J, Wolansky LJ, Cook SD, Cadavid D (2009) Serum levels of CXCL13 are elevated in active multiple sclerosis. Multiple Sclerosis Journal 15:1271\u20131279","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mce.2013.04.001","volume":"380","author":"HJ Fischer","year":"2013","unstructured":"Fischer HJ, Schweingruber N, L\u00fchder F, Reichardt HM (2013) The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Molecular and cellular endocrinology 380:99\u2013107","journal-title":"Molecular and cellular endocrinology"},{"key":"648_CR50","doi-asserted-by":"crossref","unstructured":"Fischer, I., Alliod, C., Martinier, N., Newcombe, J., Brana, C. & Pouly, S. 2011. Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PloS one, 6.","DOI":"10.1371\/journal.pone.0023905"},{"key":"648_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ana.24987","volume":"82","author":"N Fissolo","year":"2017","unstructured":"Fissolo N, Pignolet B, Matute-Blanch C, Trivi\u00f1o JC, Mir\u00f3 B, Mota M, Perez-Hoyos S, Sanchez A, Vermersch P, Ruet A (2017) Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy. Annals of neurology 82:186\u2013195","journal-title":"Annals of neurology"},{"key":"648_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0165-5728(01)00261-2","volume":"115","author":"D Franciotta","year":"2001","unstructured":"Franciotta D, Martino G, Zardini E, Furlan R, Bergamaschi R, Andreoni L, Cosi V (2001) Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. Journal of neuroimmunology 115:192\u2013198","journal-title":"Journal of neuroimmunology"},{"key":"648_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jns.2006.05.049","volume":"247","author":"D Franciotta","year":"2006","unstructured":"Franciotta D, Zardini E, Ravaglia S, Piccolo G, Andreoni L, Bergamaschi R, Romani A, Tavazzi E, Naldi P, Ceroni M (2006) Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. Journal of the neurological sciences 247:202\u2013207","journal-title":"Journal of the neurological sciences"},{"key":"648_CR54","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1468-1331.2006.01629.x","volume":"14","author":"D Galimberti","year":"2007","unstructured":"Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Lovati C, Mariani C, Monaco F, Bresolin N (2007) CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course. European journal of neurology 14:162\u2013167","journal-title":"European journal of neurology"},{"key":"648_CR55","doi-asserted-by":"crossref","unstructured":"Gandhi KS, Mckay FC, Diefenbach E, Crossett B, Schibeci SD, Heard RN, Stewart GJ, Booth DR, Arthur JW (2010) Novel approaches to detect serum biomarkers for clinical response to interferon-\u03b2 treatment in multiple sclerosis. PLoS One 5","DOI":"10.1371\/journal.pone.0010484"},{"key":"648_CR56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-017-0953-z","volume":"14","author":"V Gerzanich","year":"2017","unstructured":"Gerzanich V, Makar TK, Guda PR, Kwon MS, Stokum JA, Woo SK, Ivanova S, Ivanov A, Mehta RI, morris AB (2017) Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis. Journal of neuroinflammation 14:177","journal-title":"Journal of neuroinflammation"},{"key":"648_CR57","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1189\/jlb.1202598","volume":"73","author":"D Giunti","year":"2003","unstructured":"Giunti D, Borsellino G, Benelli R, Marchese M, Capello E, Valle MT, Pedemonte E, Noonan D, Albini A, Bernardi G (2003) Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. Journal of leukocyte biology 73:584\u2013590","journal-title":"Journal of leukocyte biology"},{"key":"648_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-3083.2003.01285.x","volume":"58","author":"A Glabinski","year":"2003","unstructured":"Glabinski A, Bielecki B, Ransohoff R (2003) Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis. Scandinavian journal of immunology 58:81\u201388","journal-title":"Scandinavian journal of immunology"},{"key":"648_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000488988","volume":"25","author":"A Glasnovi\u0107","year":"2018","unstructured":"Glasnovi\u0107 A, Stoji\u0107 M, De\u017emalj L, Tudori\u0107-\u0110eno I, Romi\u0107 D, Jele\u010d V, Vrca A, Vuleti\u0107 V, Gr\u010devi\u0107 D (2018) RANKL\/RANK\/OPG Axis Is Deregulated in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset. Neuroimmunomodulation 25:23\u201333","journal-title":"Neuroimmunomodulation"},{"key":"648_CR60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/eji.201747442","volume":"48","author":"JJ Grist","year":"2018","unstructured":"Grist JJ, Marro BS, Skinner DD, Syage AR, Worne C, Doty DJ, Fujinami RS, Lane TE (2018) Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. European journal of immunology 48:1199\u20131210","journal-title":"European journal of immunology"},{"key":"648_CR61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jaut.2011.08.003","volume":"37","author":"J Haas","year":"2011","unstructured":"Haas J, Bekeredjian-Ding I, Milkova M, Balint B, Schwarz A, Korporal M, Jarius S, Fritz B, Lorenz H-M, Wildemann B (2011) B cells undergo unique compartmentalized redistribution in multiple sclerosis. Journal of autoimmunity 37:289\u2013299","journal-title":"Journal of autoimmunity"},{"key":"648_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1165\/ajrcmb.23.1.4014","volume":"23","author":"JC Hedges","year":"2000","unstructured":"Hedges JC, Singer CA, Gerthoffer WT (2000) Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. American journal of respiratory cell and molecular biology 23:86\u201394","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"648_CR63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/1352458513503597","volume":"20","author":"H Hegen","year":"2014","unstructured":"Hegen H, Millonig A, Bertolotto A, Comabella M, Giovanonni G, Guger M, Hoelzl M, Khalil M, Killestein J, Lindberg R (2014) Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Multiple Sclerosis Journal 20:577\u2013587","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR64","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1089\/jir.2013.0097","volume":"34","author":"C Hermanrud","year":"2014","unstructured":"Hermanrud C, Ryner ML, Engdahl E, Fogdell-Hahn A (2014) Anti-interferon beta antibody titers strongly correlate between two bioassays and in vivo biomarker expression, and indicates that a titer of 150 TRU\/mL is a biologically functional cut-point. Journal of Interferon & Cytokine Research 34:498\u2013504","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"648_CR65","first-page":"1211","volume":"9","author":"MM Herrmann","year":"2016","unstructured":"Herrmann MM, Barth S, Greve B, Schumann KM, Bartels A, Weissert R (2016) Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Disease models & mechanisms 9:1211\u20131220","journal-title":"Disease models & mechanisms"},{"key":"648_CR66","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","volume":"272","author":"K Hieshima","year":"1997","unstructured":"Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, Sakaki Y, Takatsuki K, Miura R, Yoshie O (1997) Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver Chemotactic activity for lymphocytes and gene localization on chromosome 2. Journal of Biological Chemistry 272:5846\u20135853","journal-title":"Journal of Biological Chemistry"},{"key":"648_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1742-2094-8-77","volume":"8","author":"AE Hinojosa","year":"2011","unstructured":"Hinojosa AE, Garcia-Bueno B, Leza JC, Madrigal JL (2011) CCL2\/MCP-1 modulation of microglial activation and proliferation. Journal of neuroinflammation 8:77","journal-title":"Journal of neuroinflammation"},{"key":"648_CR68","doi-asserted-by":"crossref","unstructured":"Hosking, M. P., Tirotta, E., Ransohoff, R. M. & Lane, T. E. 2010. CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PloS one, 5.","DOI":"10.1371\/journal.pone.0011340"},{"key":"648_CR69","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0165-5728(01)00487-8","volume":"123","author":"C Iarlori","year":"2002","unstructured":"Iarlori C, Reale M, DE Luca G, Di Iorio A, Feliciani C, Tulli A, Conti P, Gambi D, Lugaresi A (2002) Interferon \u03b2-1b modulates MCP-1 expression and production in relapsing\u2013remitting multiple sclerosis. Journal of neuroimmunology 123:170\u2013179","journal-title":"Journal of neuroimmunology"},{"key":"648_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ana.20875","volume":"60","author":"I Ifergan","year":"2006","unstructured":"Ifergan I, Wosik K, Cayrol R, K\u00e9bir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Prat A (2006) Statins reduce human blood\u2013brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Annals of neurology 60:45\u201355","journal-title":"Annals of neurology"},{"key":"648_CR71","first-page":"5596","volume":"10","author":"N Iida","year":"1990","unstructured":"Iida N, Grotendorst GR (1990) Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Molecular and cellular biology 10:5596\u20135599","journal-title":"Molecular and cellular biology"},{"key":"648_CR72","first-page":"58","volume":"8","author":"M Imai","year":"2008","unstructured":"Imai M, Watanabe M, Suyama K, Osada T, Sakai D, Kawada H, Matsumae M, Mochida J (2008) Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model. Journal of Neurosurgery: Spine 8:58\u201366","journal-title":"Journal of Neurosurgery: Spine"},{"key":"648_CR73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jns.2017.06.048","volume":"380","author":"P Iwanowski","year":"2017","unstructured":"Iwanowski P, Losy J, Kramer L, W\u00f3jcicka M, Kaufman E (2017) CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis. Journal of the neurological sciences 380:22\u201326","journal-title":"Journal of the neurological sciences"},{"key":"648_CR74","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1055\/s-0043-113455","volume":"67","author":"A Jafarzadeh","year":"2017","unstructured":"Jafarzadeh A, Arabi Z, Ahangar-Parvin R, Mohammadi-Kordkhayli M, Nemati M (2017) Ginger extract modulates the expression of chemokines CCL20 and CCL22 and their receptors (CCR6 and CCR4) in the central nervous system of mice with experimental autoimmune encephalomyelitis. Drug research 67:632\u2013639","journal-title":"Drug research"},{"key":"648_CR75","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12031-013-0214-2","volume":"53","author":"A Jafarzadeh","year":"2014","unstructured":"Jafarzadeh A, Bagherzadeh S, Ebrahimi H, Hajghani H, Bazrafshani M, Khosravimashizi A, Nemati M, Gadari F, Sabahi A, Iranmanesh F (2014) Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern. Journal of Molecular Neuroscience 53:500\u2013505","journal-title":"Journal of Molecular Neuroscience"},{"key":"648_CR76","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/01616412.2017.1301623","volume":"39","author":"MR Javan","year":"2017","unstructured":"Javan MR, Shahraki S, Safa A, Zamani MR, Salmaninejad A, Aslani S (2017) An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remitting multiple sclerosis. Neurol Res 39:435\u2013441","journal-title":"Neurol Res"},{"key":"648_CR77","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0165-5728(02)00147-9","volume":"128","author":"Y Jee","year":"2002","unstructured":"Jee Y, Yoon WK, Okura Y, Tanuma N, Matsumoto Y (2002) Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. Journal of neuroimmunology 128:49\u201357","journal-title":"Journal of neuroimmunology"},{"key":"648_CR78","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.4049\/jimmunol.1501613","volume":"196","author":"W Jiang","year":"2016","unstructured":"Jiang W, St-Pierre S, Roy P, Morley BJ, Hao J, Simard AR (2016) Infiltration of CCR2+ Ly6Chigh proinflammatory monocytes and neutrophils into the central nervous system is modulated by nicotinic acetylcholine receptors in a model of multiple sclerosis. The Journal of Immunology 196:2095\u20132108","journal-title":"The Journal of Immunology"},{"key":"648_CR79","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/archneurol.2010.312","volume":"67","author":"TA Johnson","year":"2010","unstructured":"Johnson TA, Lapierre Y, Bar-Or A, Antel JP (2010) Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis. Archives of neurology 67:1449\u20131455","journal-title":"Archives of neurology"},{"key":"648_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2010.09.026","volume":"300","author":"A Kalinowska-\u0141yszczarz","year":"2011","unstructured":"Kalinowska-\u0141yszczarz A, Szczuci\u0144ski A, Pawlak MA, Losy J (2011) Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing\u2212 remitting multiple sclerosis patients. Journal of the neurological sciences 300:81\u201385","journal-title":"Journal of the neurological sciences"},{"key":"648_CR81","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2006.05.033","volume":"404","author":"E Kamali-Sarvestani","year":"2006","unstructured":"Kamali-Sarvestani E, Nikseresht A-R, Aliparasti M-R, Vessal M (2006) IL-8 (\u2212 251 A\/T) and CXCR2 (+ 1208 C\/T) gene polymorphisms and risk of multiple sclerosis in Iranian patients. Neuroscience letters 404:159\u2013162","journal-title":"Neuroscience letters"},{"key":"648_CR82","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12026-013-8393-z","volume":"56","author":"Q-C Kan","year":"2013","unstructured":"Kan Q-C, Zhu L, Liu N, Zhang G-X (2013) Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity. Immunologic research 56:189\u2013196","journal-title":"Immunologic research"},{"key":"648_CR83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/intimm\/dxw013","volume":"28","author":"M Kanayama","year":"2016","unstructured":"Kanayama M, Danzaki K, He Y-W, Shinohara ML (2016) Lung inflammation stalls Th17-cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis. International immunology 28:463\u2013469","journal-title":"International immunology"},{"key":"648_CR84","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1073\/pnas.1721732115","volume":"115","author":"H Karim","year":"2018","unstructured":"Karim H, Kim SH, Lapato AS, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK (2018) Increase in chemokine CXCL1 by ER\u03b2 ligand treatment is a key mediator in promoting axon myelination. Proceedings of the National Academy of Sciences 115:6291\u20136296","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"648_CR85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2008.06.039","volume":"203","author":"WJ Karpus","year":"2008","unstructured":"Karpus WJ, Reynolds N, Behanna HA, Van Eldik LJ, Watterson DM (2008) Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug. Journal of neuroimmunology 203:73\u201378","journal-title":"Journal of neuroimmunology"},{"key":"648_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2007.11.006","volume":"194","author":"J Kawanokuchi","year":"2008","unstructured":"Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A (2008) Production and functions of IL-17 in microglia. Journal of neuroimmunology 194:54\u201361","journal-title":"Journal of neuroimmunology"},{"key":"648_CR87","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1126\/science.7973732","volume":"266","author":"GS Kelner","year":"1994","unstructured":"Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ (1994) Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395\u20131399","journal-title":"Science"},{"key":"648_CR88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jri.2018.02.006","volume":"126","author":"P Kempe","year":"2018","unstructured":"Kempe P, Eklund D, Hallin A, Hammar M, Olsson T, Brynhildsen J, Ernerudh J (2018) Immune profile in relation to sex steroid cyclicity in healthy women and women with multiple sclerosis. Journal of reproductive immunology 126:53\u201359","journal-title":"Journal of reproductive immunology"},{"key":"648_CR89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1352458510389102","volume":"17","author":"M Khademi","year":"2011","unstructured":"Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T (2011) Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Multiple Sclerosis Journal 17:335\u2013343","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR90","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0361-9230(03)00096-0","volume":"61","author":"TO Kleine","year":"2003","unstructured":"Kleine TO, Zwerenz P, Graser C, Z\u00f6fel P (2003) Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-\u03b1, IL-1\u03b2, IL-6, IL-8. Brain research bulletin 61:327\u2013346","journal-title":"Brain research bulletin"},{"key":"648_CR91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.24408","volume":"78","author":"M Komori","year":"2015","unstructured":"Komori M, Blake A, Greenwood M, Lin YC, Kosa P, Ghazali D, Winokur P, Natrajan M, Wuest SC, Romm E (2015) Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Annals of neurology 78:3\u201320","journal-title":"Annals of neurology"},{"key":"648_CR92","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-014-1244-8","volume":"127","author":"G Kooij","year":"2014","unstructured":"Kooij G, Kroon J, Paul D, Reijerkerk A, Geerts D, Van Der Pol SM, Van Het Hof B, Drexhage JA, Van Vliet SJ, Hekking LH (2014) P-glycoprotein regulates trafficking of CD8+ T cells to the brain parenchyma. Acta neuropathologica 127:699\u2013711","journal-title":"Acta neuropathologica"},{"key":"648_CR93","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/brain\/awq330","volume":"134","author":"G Kooij","year":"2011","unstructured":"Kooij G, Mizee MR, Van Horssen J, Reijerkerk A, Witte ME, Drexhage JA, Van Der Pol SM, Van Het Hof B, Scheffer G, Scheper R (2011) Adenosine triphosphate-binding cassette transporters mediate chemokine (CC motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain 134:555\u2013570","journal-title":"Brain"},{"key":"648_CR94","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1399-0039.2004.00240.x","volume":"64","author":"A Kroner","year":"2004","unstructured":"Kroner A, M\u00e4urer M, Loserth S, Kleinschnitz C, Hemmer B, Rosche B, Toyka K, Rieckmann P (2004) Analysis of the monocyte chemoattractant protein 1\u2212 2518 promoter polymorphism in patients with multiple sclerosis. Tissue Antigens 64:70\u201373","journal-title":"Tissue Antigens"},{"key":"648_CR95","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/brain\/awh680","volume":"129","author":"M Krumbholz","year":"2006","unstructured":"Krumbholz M, Theil D, Cepok S, Hemmer B, Kivis\u00e4kk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129:200\u2013211","journal-title":"Brain"},{"key":"648_CR96","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2217\/pgs.14.26","volume":"15","author":"OG Kulakova","year":"2014","unstructured":"Kulakova OG, Tsareva EY, Lvovs D, Favorov AV, Boyko AN, Favorova OO (2014) Comparative pharmacogenetics of multiple sclerosis: IFN-\u03b2 versus glatiramer acetate. Pharmacogenomics 15:679\u2013685","journal-title":"Pharmacogenomics"},{"key":"648_CR97","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.187.4.655","volume":"187","author":"DF Legler","year":"1998","unstructured":"Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B (1998) B cell\u2013attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5. The Journal of experimental medicine 187:655\u2013660","journal-title":"The Journal of experimental medicine"},{"key":"648_CR98","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12974-019-1601-6","volume":"16","author":"G Lepennetier","year":"2019","unstructured":"Lepennetier G, Hracsko Z, Unger M, Van Griensven M, Grummel V, Krumbholz M, Berthele A, Hemmer B, Kowarik MC (2019) Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases. Journal of neuroinflammation 16:219","journal-title":"Journal of neuroinflammation"},{"key":"648_CR99","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1084\/jem.20151437","volume":"213","author":"SA L\u00e9vesque","year":"2016","unstructured":"L\u00e9vesque SA, Par\u00e9 A, Mailhot B, Bellver-Landete V, K\u00e9bir H, L\u00e9cuyer M-A, Alvarez JI, Prat A, Vaccari JPDR, Keane RW (2016) Myeloid cell transmigration across the CNS vasculature triggers IL-1\u03b2\u2013driven neuroinflammation during autoimmune encephalomyelitis in mice. Journal of Experimental Medicine 213:929\u2013949","journal-title":"Journal of Experimental Medicine"},{"key":"648_CR100","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2017.10.013","volume":"313","author":"R Li","year":"2017","unstructured":"Li R, Sun X, Shu Y, Wang Y, Xiao L, Wang Z, Hu X, Kermode AG, Qiu W (2017) Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients. Journal of neuroimmunology 313:56\u201360","journal-title":"Journal of neuroimmunology"},{"key":"648_CR101","doi-asserted-by":"crossref","unstructured":"Li R, Xu W, Chen Y, Qiu W, Shu Y, Wu A, Dai Y, Bao J, Lu Z, Hu X (2014) Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-\u03baB-dependent CCL20 expression in reactive astrocytes. PLoS One, 9.","DOI":"10.1371\/journal.pone.0094320"},{"key":"648_CR102","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/1352458512463482","volume":"19","author":"M Lind\u00e9n","year":"2013","unstructured":"Lind\u00e9n M, Khademi M, Lima Bomfim I, Piehl F, Jagodic M, Kockum I, Olsson T (2013) Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13. Multiple sclerosis journal 19:863\u2013870","journal-title":"Multiple sclerosis journal"},{"key":"648_CR103","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.4049\/jimmunol.0713169","volume":"182","author":"A Liston","year":"2009","unstructured":"Liston A, Kohler RE, Townley S, Haylock-Jacobs S, Comerford I, Caon AC, Webster J, Harrison JM, Swann J, Clark-Lewis I (2009) Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. The Journal of Immunology 182:3121\u20133130","journal-title":"The Journal of Immunology"},{"key":"648_CR104","doi-asserted-by":"crossref","unstructured":"Lomakin, Y., Belogurov, A., Glagoleva, I., Stepanov, A., Zakharov, K., Okunola, J., Smirnov, I., Genkin, D. & Gabibov, A. 2016. Administration of myelin basic protein peptides encapsulated in mannosylated liposomes normalizes level of serum TNF-\u03b1 and IL-2 and chemoattractants ccl2 and ccl4 in multiple sclerosis patients. Mediators of inflammation, 2016.","DOI":"10.1155\/2016\/2847232"},{"key":"648_CR105","first-page":"583","volume":"35","author":"J Losy","year":"2001","unstructured":"Losy J, Micha\u0142owska-Wender G, Wender M (2001) Chemokines MIP-1 and MCP-1 and patients with multiple sclerosis treated with interferon beta-1a. Neurologia i neurochirurgia polska 35:583\u2013588","journal-title":"Neurologia i neurochirurgia polska"},{"key":"648_CR106","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.nbd.2017.02.002","volume":"102","author":"F L\u00fchder","year":"2017","unstructured":"L\u00fchder F, Kebir H, Odoardi F, Litke T, Sonneck M, Alvarez JI, Winchenbach J, Eckert N, Hayardeny L, Sorani E (2017) Laquinimod enhances central nervous system barrier functions. Neurobiology of disease 102:60\u201369","journal-title":"Neurobiology of disease"},{"key":"648_CR107","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/315672a0","volume":"315","author":"AD Luster","year":"1985","unstructured":"Luster AD, Unkeless JC, Ravetch JV (1985) \u03b3-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672\u2013676","journal-title":"Nature"},{"key":"648_CR108","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/brain\/awh655","volume":"129","author":"D Mahad","year":"2006","unstructured":"Mahad D, Callahan MK, Williams KA, Ubogu EE, Kivis\u00e4kk P, Tucky B, Kidd G, Kingsbury GA, Chang A, Fox RJ (2006) Modulating CCR2 and CCL2 at the blood\u2013brain barrier: relevance for multiple sclerosis pathogenesis. Brain 129:212\u2013223","journal-title":"Brain"},{"key":"648_CR109","doi-asserted-by":"crossref","unstructured":"Mahad DJ, Ransohoff RM (2003) The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Seminars in immunology, Elsevier, 23-32","DOI":"10.1016\/S1044-5323(02)00125-2"},{"key":"648_CR110","first-page":"425","volume":"74","author":"R Mahdavi","year":"2016","unstructured":"Mahdavi R, Jamali M, Rostami M, Safa A, Jafarzadeh A, Naseri M (2016) FOXP3 polymorphism rs2232365 and its association with multiple sclerosis susceptibility. Tehran University Medical Journal TUMS Publications 74:425\u2013432","journal-title":"Tehran University Medical Journal TUMS Publications"},{"key":"648_CR111","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jneuroim.2006.03.004","volume":"175","author":"C MALMESTR\u00d6M","year":"2006","unstructured":"MALMESTR\u00d6M C, Andersson B, Haghighi S, Lycke J (2006) IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles. Journal of neuroimmunology 175:176\u2013182","journal-title":"Journal of neuroimmunology"},{"key":"648_CR112","doi-asserted-by":"crossref","unstructured":"Martin NA, Nawrocki A, Molnar V, Elkjaer ML, Thygesen EK, Palkovits M, Acs P, Sejbaek T, Nielsen HH, Hegedus Z (2018) Orthologous proteins of experimental de-and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes. PloS one, 13","DOI":"10.1371\/journal.pone.0202530"},{"key":"648_CR113","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0165-5728(00)00236-8","volume":"107","author":"G Martino","year":"2000","unstructured":"Martino G, Poliani PL, Furlan R, Marconi P, Glorioso JC, Adorini L, Comi G (2000) Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. Journal of neuroimmunology 107:184\u2013190","journal-title":"Journal of neuroimmunology"},{"key":"648_CR114","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2017.03.007","volume":"14","author":"Z Matej\u010d\u00edkov\u00e1","year":"2017","unstructured":"Matej\u010d\u00edkov\u00e1 Z, Mare\u0161 J, Sl\u00e1dkov\u00e1 V, Svr\u010dinov\u00e1 T, Vyslou\u017eilov\u00e1 J, Zapletalov\u00e1 J, Ka\u0148ovsk\u00fd P (2017) Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin. Multiple sclerosis and related disorders 14:12\u201315","journal-title":"Multiple sclerosis and related disorders"},{"key":"648_CR115","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, Mascanfroni ID, Yeste A, Kivis\u00e4kk P, Kallas K (2014) Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nature medicine 20:1147","journal-title":"Nature medicine"},{"key":"648_CR116","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2353\/ajpath.2008.070918","volume":"172","author":"EE Mccandless","year":"2008","unstructured":"Mccandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS (2008) Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. The American journal of pathology 172:799\u2013808","journal-title":"The American journal of pathology"},{"key":"648_CR117","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","volume":"59","author":"M Mecha","year":"2013","unstructured":"Mecha M, Feli\u00fa A, I\u00f1igo P, Mestre L, Carrillo-Salinas F, Guaza C (2013) Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiology of disease 59:141\u2013150","journal-title":"Neurobiology of disease"},{"key":"648_CR118","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/1352458509355068","volume":"16","author":"J Mellerg\u00e5rd","year":"2010","unstructured":"Mellerg\u00e5rd J, Edstr\u00f6m M, Vrethem M, Ernerudh J, Dahle C (2010) Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid. Multiple Sclerosis Journal 16:208\u2013217","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR119","doi-asserted-by":"crossref","unstructured":"Mellerg\u00e5rd J, Tisell A, Leinhard OD, Blystad I, Landtblom A-M, Blennow K, Olsson B, Dahle C, Ernerudh J, Lundberg P (2012) Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis. PloS one, 7.","DOI":"10.1371\/journal.pone.0044739"},{"key":"648_CR120","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jocn.2010.03.022","volume":"17","author":"A Messadi","year":"2010","unstructured":"Messadi A, Fekih-Mrissa N, Kallel A, Bouguerra C, Sediri Y, Zaweli J, Laayouni S, Nciri B, Yedeas M, Mrissa R (2010) Lack of association between monocyte protein-1 (MCP-1)\u20132518 A> G chemoattractant and C\u2013C chemokine receptor 2 (CCR2) Val64Ile polymorphisms and multiple sclerosis in a Tunisian population. Journal of Clinical Neuroscience 17:1311\u20131313","journal-title":"Journal of Clinical Neuroscience"},{"key":"648_CR121","first-page":"549","volume":"60","author":"G Micha\u0142owska-Wender","year":"2008","unstructured":"Micha\u0142owska-Wender G, Losy J, Biernacka-\u0141ukanty J, Wender M (2008) Impact of methylprednisolone treatment on the expression of macrophage inflammatory protein 3alpha and B lymphocyte chemoattractant in serum of multiple sclerosis patients. Pharmacological reports: PR 60:549\u2013554","journal-title":"Pharmacological reports: PR"},{"key":"648_CR122","first-page":"920","volume":"58","author":"G Micha\u0142owska-Wender","year":"2006","unstructured":"Micha\u0142owska-Wender G, Losy J, Szczuci\u0144ski A, Biernacka-\u0141ukanty J, Wender M (2006) Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients. Pharmacological reports: PR 58:920\u2013923","journal-title":"Pharmacological reports: PR"},{"key":"648_CR123","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","volume":"11","author":"O Mikova","year":"2001","unstructured":"Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. European Neuropsychopharmacology 11:203\u2013208","journal-title":"European Neuropsychopharmacology"},{"key":"648_CR124","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.imbio.2011.03.013","volume":"216","author":"D Miljkovi\u0107","year":"2011","unstructured":"Miljkovi\u0107 D, Stanojevi\u0107 \u017d, Momcilovi\u0107 M, Odoardi F, Fl\u00fcgel A, Mostarica-Stojkovi\u0107 M (2011) CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats. Immunobiology 216:979\u2013987","journal-title":"Immunobiology"},{"key":"648_CR125","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"DH Miller","year":"2003","unstructured":"Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. New England Journal of Medicine 348:15\u201323","journal-title":"New England Journal of Medicine"},{"key":"648_CR126","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3109\/08923970903486625","volume":"32","author":"D Mirowska-Guzel","year":"2010","unstructured":"Mirowska-Guzel D, Gromadzka G, Kurowska K, Czlonkowski A, Czlonkowska A (2010) Long-term effect of high doses glucocorticosteroids on mRNA expression for IL-6 and IL-8 in relapsed multiple sclerosis patients. Immunopharmacology and immunotoxicology 32:416\u2013421","journal-title":"Immunopharmacology and immunotoxicology"},{"key":"648_CR127","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF00208938","volume":"84","author":"WS Modi","year":"1990","unstructured":"Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O'Brien SJ (1990) Monocyte-derived neutrophil chemotactic factor (MDNCF\/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Human genetics 84:185\u2013187","journal-title":"Human genetics"},{"key":"648_CR128","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40478-014-0168-9","volume":"2","author":"H Mohan","year":"2014","unstructured":"Mohan H, Friese A, Albrecht S, Krumbholz M, Elliott CL, Arthur A, Menon R, Farina C, Junker A, Stadelmann C (2014) Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination. Acta neuropathologica communications 2:178","journal-title":"Acta neuropathologica communications"},{"key":"648_CR129","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archneurol.2008.512","volume":"66","author":"NM Moll","year":"2009","unstructured":"Moll NM, Cossoy MB, Fisher E, Staugaitis SM, Tucky BH, Rietsch AM, Chang A, Fox RJ, Trapp BD, Ransohoff RM (2009) Imaging correlates of leukocyte accumulation and CXCR4\/CXCL12 in multiple sclerosis. Archives of neurology 66:44\u201353","journal-title":"Archives of neurology"},{"key":"648_CR130","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1600-0404.2006.00629.x","volume":"114","author":"M Moreira","year":"2006","unstructured":"Moreira M, Tilbery C, Monteiro L, Teixeira M, Teixeira A (2006) Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. Acta neurologica scandinavica 114:109\u2013113","journal-title":"Acta neurologica scandinavica"},{"key":"648_CR131","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.171.5.1797","volume":"171","author":"B Moser","year":"1990","unstructured":"Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M (1990) Neutrophil-activating properties of the melanoma growth-stimulatory activity. The Journal of experimental medicine 171:1797\u20131802","journal-title":"The Journal of experimental medicine"},{"key":"648_CR132","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2012.06.008","volume":"251","author":"AM M\u00fcller","year":"2012","unstructured":"M\u00fcller AM, Jun E, Conlon H, Sadiq SA (2012) Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis. Journal of neuroimmunology 251:80\u201386","journal-title":"Journal of neuroimmunology"},{"key":"648_CR133","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.mcn.2009.11.008","volume":"43","author":"L Muzio","year":"2010","unstructured":"Muzio L, Cavasinni F, Marinaro C, Bergamaschi A, Bergami A, Porcheri C, Cerri F, Dina G, Quattrini A, Comi G (2010) Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis. Molecular and Cellular Neuroscience 43:268\u2013280","journal-title":"Molecular and Cellular Neuroscience"},{"key":"648_CR134","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000081856","volume":"52","author":"H Nakajima","year":"2004","unstructured":"Nakajima H, Fukuda K, Doi Y, Sugino M, Kimura F, Hanafusa T, Ikemoto T, Shimizu A (2004) Expression of TH1\/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis. European neurology 52:162\u2013168","journal-title":"European neurology"},{"key":"648_CR135","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1177\/1352458509107009","volume":"15","author":"RF Neuteboom","year":"2009","unstructured":"Neuteboom RF, Verbraak E, Voerman JS, Van Meurs M, Steegers EA, De Groot CJ, Laman JD, Hintzen RQ (2009) First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis. Multiple Sclerosis Journal 15:1356\u20131358","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR136","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cytogfr.2010.03.004","volume":"21","author":"H Nomiyama","year":"2010","unstructured":"Nomiyama H, Osada N, Yoshie O (2010) The evolution of mammalian chemokine genes. Cytokine & growth factor reviews 21:253\u2013262","journal-title":"Cytokine & growth factor reviews"},{"key":"648_CR137","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.dci.2011.01.019","volume":"35","author":"H Nomiyama","year":"2011","unstructured":"Nomiyama H, Osada N, Yoshie O (2011) A family tree of vertebrate chemokine receptors for a unified nomenclature. Developmental & Comparative Immunology 35:705\u2013715","journal-title":"Developmental & Comparative Immunology"},{"key":"648_CR138","doi-asserted-by":"crossref","unstructured":"Oettgen, H. & Broide, D. H. 2011. Introduction to mechanisms of allergic. Allergy E-Book: Expert Consult Online and Print, 1.","DOI":"10.1016\/B978-0-7234-3658-4.00005-6"},{"key":"648_CR139","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.20246","volume":"53","author":"KM Omari","year":"2006","unstructured":"Omari KM, John G, Lango R, Raine CS (2006) Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53:24\u201331","journal-title":"Glia"},{"key":"648_CR140","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1212\/01.wnl.0000436612.66328.8a","volume":"81","author":"L Ottoboni","year":"2013","unstructured":"Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL (2013) Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology 81:1891\u20131899","journal-title":"Neurology"},{"key":"648_CR141","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0165-5728(02)00441-1","volume":"135","author":"M Pashenkov","year":"2003","unstructured":"Pashenkov M, S\u00f6derstr\u00f6m M, Link H (2003) Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. Journal of Neuroimmunology 135:154\u2013160","journal-title":"Journal of Neuroimmunology"},{"key":"648_CR142","doi-asserted-by":"publisher","first-page":"11062","DOI":"10.1073\/pnas.1006301107","volume":"107","author":"JR Patel","year":"2010","unstructured":"Patel JR, Mccandless EE, Dorsey D, Klein RS (2010) CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proceedings of the National Academy of Sciences 107:11062\u201311067","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"648_CR143","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00401-012-1034-0","volume":"124","author":"JR Patel","year":"2012","unstructured":"Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, Klein RS (2012) Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta neuropathologica 124:847\u2013860","journal-title":"Acta neuropathologica"},{"key":"648_CR144","doi-asserted-by":"crossref","unstructured":"Perry, J. S., Han, S., Xu, Q., Herman, M. L., Kennedy, L. B., Csako, G. & Bielekova, B. 2012. Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis. Science translational medicine, 4, 145ra106-145ra106.","DOI":"10.1126\/scitranslmed.3004140"},{"key":"648_CR145","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/icb.2013.23","volume":"91","author":"F Petkovi\u0107","year":"2013","unstructured":"Petkovi\u0107 F, Bla\u017eevski J, Mom\u010dilovi\u0107 M, Mostarica Stojkovic M, Miljkovi\u0107 D (2013) Nitric oxide inhibits CXCL12 expression in neuroinflammation. Immunology and cell biology 91:427\u2013434","journal-title":"Immunology and cell biology"},{"key":"648_CR146","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-017-0487-8","volume":"5","author":"K Pollok","year":"2017","unstructured":"Pollok K, Mothes R, Ulbricht C, Liebheit A, Gerken JD, Uhlmann S, Paul F, Niesner R, Radbruch H, Hauser AE (2017) The chronically inflamed central nervous system provides niches for long-lived plasma cells. Acta neuropathologica communications 5:88","journal-title":"Acta neuropathologica communications"},{"key":"648_CR147","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archneur.59.3.391","volume":"59","author":"A Prat","year":"2002","unstructured":"Prat A, Biernacki K, Lavoie J-F, Poirier J, Duquette P, Antel JP (2002) Migration of multiple sclerosis lymphocytes through brain endothelium. Archives of neurology 59:391\u2013397","journal-title":"Archives of neurology"},{"key":"648_CR148","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-014-0098-6","volume":"2","author":"M Prins","year":"2014","unstructured":"Prins M, Dutta R, Baselmans B, Brev\u00e9 JJ, Bol JG, Deckard SA, Van Der Valk P, Amor S, Trapp BD, De Vries HE (2014a) Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients. Acta neuropathologica communications 2:98","journal-title":"Acta neuropathologica communications"},{"key":"648_CR149","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-014-0098-6","volume":"2","author":"M Prins","year":"2014","unstructured":"Prins M, Dutta R, Baselmans B, Brev\u00e9 JJP, Bol JGJM, Deckard SA, Van Der Valk P, Amor S, Trapp BD, De Vries HE, Drukarch B, Van Dam A-M (2014b) Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients. Acta neuropathologica communications 2:98\u201398","journal-title":"Acta neuropathologica communications"},{"key":"648_CR150","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-016-0785-2","volume":"14","author":"M Puthenparampil","year":"2017","unstructured":"Puthenparampil M, Federle L, Miante S, Zito A, Toffanin E, Ruggero S, Ermani M, Pravato S, Poggiali D, Perini P (2017) BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset. Journal of neuroinflammation 14:11","journal-title":"Journal of neuroinflammation"},{"key":"648_CR151","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/1352458511398887","volume":"17","author":"S Ragheb","year":"2011","unstructured":"Ragheb S, Li Y, Simon K, Vanhaerents S, Galimberti D, De Riz M, Fenoglio C, Scarpini E, Lisak R (2011) Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. Multiple Sclerosis Journal 17:819\u2013829","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR152","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F (2009) CC chemokine receptor 6\u2013regulated entry of T H-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nature immunology 10:514","journal-title":"Nature immunology"},{"key":"648_CR153","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.clineuro.2008.06.005","volume":"110","author":"M Rentzos","year":"2008","unstructured":"Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Kararizou E, Koutsis G, Zoga M, Dimitrakopoulos A, Tsoutsou A, Sfangos C (2008) Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse. Clinical neurology and neurosurgery 110:992\u2013996","journal-title":"Clinical neurology and neurosurgery"},{"key":"648_CR154","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/1352458514564482","volume":"21","author":"S Rossi","year":"2015","unstructured":"Rossi S, Motta C, Studer V, Macchiarulo G, Germani G, Finardi A, Furlan R, Martino G, Centonze D (2015) Subclinical central inflammation is risk for RIS and CIS conversion to MS. Multiple Sclerosis Journal 21:1443\u20131452","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR155","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1177\/1352458514537365","volume":"20","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V, Rocchi C, Macchiarulo G, Barbieri F, Marfia G, Furlan R, Martino G, Mancino R (2014) Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis. Multiple Sclerosis Journal 20:1841\u20131850","journal-title":"Multiple Sclerosis Journal"},{"key":"648_CR156","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, Chao C-C, Patel B, Yan R, Blain M (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nature medicine 22:586","journal-title":"Nature medicine"},{"key":"648_CR157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1084\/jem.20141015","volume":"212","author":"JM Rumble","year":"2015","unstructured":"Rumble JM, Huber AK, Krishnamoorthy G, Srinivasan A, Giles DA, Zhang X, Wang L, Segal BM (2015) Neutrophil-related factors as biomarkers in EAE and MS. Journal of Experimental Medicine 212:23\u201335","journal-title":"Journal of Experimental Medicine"},{"key":"648_CR158","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/jnen\/60.11.1087","volume":"60","author":"K Ruprecht","year":"2001","unstructured":"Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Br\u00fcck W, Rieckmann P (2001) Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. Journal of Neuropathology & Experimental Neurology 60:1087\u20131098","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"648_CR159","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cyto.2016.04.006","volume":"83","author":"A Safa","year":"2016","unstructured":"Safa A, Rashidinejad H, Khalili M, Dabiri S, Nemati M, Mohammadi M, Jafarzadeh A (2016) Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease. Cytokine 83:147\u2013157","journal-title":"Cytokine"},{"key":"648_CR160","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/10799900260100114","volume":"22","author":"A Salmaggi","year":"2002","unstructured":"Salmaggi A, Gelati M, Dufour A, Corsini E, Pagano S, Baccalini R, Ferrero E, Scabini S, Silei V, Ciusani E (2002) Expression and modulation of IFN-\u03b3-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. Journal of interferon & cytokine research 22:631\u2013640","journal-title":"Journal of interferon & cytokine research"},{"key":"648_CR161","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jsbmb.2013.10.018","volume":"144","author":"I Sanseverino","year":"2014","unstructured":"Sanseverino I, Rinaldi AO, Purificato C, Cortese A, Millefiorini E, Gessani S, Gauzzi MC (2014) CCL2 induction by 1, 25 (OH) 2D3 in dendritic cells from healthy donors and multiple sclerosis patients. The Journal of steroid biochemistry and molecular biology 144:102\u2013105","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"key":"648_CR162","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli G, Yent\u00fcr SP, Akman-Demir G, I\u015fik N, Serdaro\u011flu P (2003) Cytokines and chemokines in neuro-Beh\u00e7et's disease compared to multiple sclerosis and other neurological diseases. Journal of neuroimmunology 145:127\u2013134","journal-title":"Journal of neuroimmunology"},{"key":"648_CR163","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0022-510X(01)00680-3","volume":"195","author":"E Scarpini","year":"2002","unstructured":"Scarpini E, Galimberti D, Baron P, Clerici R, Ronzoni M, Conti G, Scarlato G (2002) IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. Journal of the neurological sciences 195:41\u201346","journal-title":"Journal of the neurological sciences"},{"key":"648_CR164","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/sj.bjc.6600221","volume":"86","author":"A Schrader","year":"2002","unstructured":"Schrader A, Lechner O, Templin M, Dittmar K, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P (2002) CXCR4\/CXCL12 expression and signalling in kidney cancer. British journal of cancer 86:1250\u20131256","journal-title":"British journal of cancer"},{"key":"648_CR165","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/WNL.0b013e3181c5b457","volume":"73","author":"F Sellebjerg","year":"2009","unstructured":"Sellebjerg F, B\u00f6rnsen L, Khademi M, Krakauer M, Olsson T, Frederiksen J, S\u00f8rensen P (2009a) Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 73:2003\u20132010","journal-title":"Neurology"},{"key":"648_CR166","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1468-1331.2009.02716.x","volume":"16","author":"F Sellebjerg","year":"2009","unstructured":"Sellebjerg F, Krakauer M, Hesse D, Ryder L, Alsing I, Jensen P, Koch-Henriksen N, Svejgaard A, Soelberg S\u00f8rensen P (2009b) Identification of new sensitive biomarkers for the in vivo response to interferon-\u03b2 treatment in multiple sclerosis using DNA-array evaluation. European journal of neurology 16:1291\u20131298","journal-title":"European journal of neurology"},{"key":"648_CR167","doi-asserted-by":"crossref","unstructured":"\u015een M, Akbayir E, Mercan \u00d6, Arsoy E, Gencer M, Yilmaz V, K\u00fc\u00e7\u00fckali C\u0130, T\u00fcz\u00fcn E, T\u00fcrko\u011flu R (2019) Cytokine\u2013chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement. The journal of spinal cord medicine, 1-7","DOI":"10.1080\/10790268.2019.1666238"},{"key":"648_CR168","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10787-014-0214-z","volume":"22","author":"M Sexton","year":"2014","unstructured":"Sexton M, Cudaback E, Abdullah RA, Finnell J, Mischley LK, Rozga M, Lichtman AH, Stella N (2014) Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology 22:295\u2013303","journal-title":"Inflammopharmacology"},{"key":"648_CR169","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.intimp.2014.06.035","volume":"22","author":"MH Seyedzadeh","year":"2014","unstructured":"Seyedzadeh MH, Safari Z, Zare A, Navashenaq JG, Kardar GA, Khorramizadeh MR (2014) Study of curcumin immunomodulatory effects on reactive astrocyte cell function. International immunopharmacology 22:230\u2013235","journal-title":"International immunopharmacology"},{"key":"648_CR170","doi-asserted-by":"crossref","unstructured":"Sharma P, Azebi S, England P, Christensen T, M\u00f8ller-Larsen A, Petersen T, Batsche E, Muchardt C (2012) Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS genetics, 8.","DOI":"10.1371\/journal.pgen.1002934"},{"key":"648_CR171","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000329576","volume":"66","author":"Y Shimizu","year":"2011","unstructured":"Shimizu Y, Ota K, Kubo S, Kabasawa C, Kobayashi M, Ohashi T, Uchiyama S (2011) Association of Th1\/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica. European neurology 66:91\u201397","journal-title":"European neurology"},{"key":"648_CR172","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0165-5728(97)00208-7","volume":"84","author":"J Simpson","year":"1998","unstructured":"Simpson J, Newcombe J, Cuzner M, Woodroofe M (1998) Expression of monocyte chemoattractant protein-1 and other \u03b2-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. Journal of neuroimmunology 84:238\u2013249","journal-title":"Journal of neuroimmunology"},{"key":"648_CR173","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-2990.2000.026002133.x","volume":"26","author":"J Simpson","year":"2000","unstructured":"Simpson J, Newcombe J, Cuzner M, Woodroofe M (2000a) Expression of the interferon-\u03b3-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathology and applied neurobiology 26:133\u2013142","journal-title":"Neuropathology and applied neurobiology"},{"key":"648_CR174","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0165-5728(00)00274-5","volume":"108","author":"J Simpson","year":"2000","unstructured":"Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN (2000b) Expression of the \u03b2-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. Journal of neuroimmunology 108:192\u2013200","journal-title":"Journal of neuroimmunology"},{"key":"648_CR175","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0165-5728(02)00263-1","volume":"131","author":"E Sindern","year":"2002","unstructured":"Sindern E, Patzold T, Ossege LM, Gisevius A, Malin J-P (2002) Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing\u2013remitting multiple sclerosis. Journal of neuroimmunology 131:186\u2013190","journal-title":"Journal of neuroimmunology"},{"key":"648_CR176","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2017.02.017","volume":"306","author":"S Sisay","year":"2017","unstructured":"Sisay S, Lopez-Lozano L, Mickunas M, Quiroga-Fern\u00e1ndez A, Palace J, Warnes G, Lafuente RA, Dua P, Meier U-C (2017) Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS. Journal of neuroimmunology 306:40\u201345","journal-title":"Journal of neuroimmunology"},{"key":"648_CR177","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/15321819.2019.1613242","volume":"40","author":"M Soleimani","year":"2019","unstructured":"Soleimani M, Soleymani A, Seyyedirad N (2019) Elevated CSF concentration of CCL3 and CCL4 in relapsing remitting multiple sclerosis patients. Journal of Immunoassay and Immunochemistry 40:378\u2013385","journal-title":"Journal of Immunoassay and Immunochemistry"},{"key":"648_CR178","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1468-1331.2004.00796.x","volume":"11","author":"TL S\u00f8rensen","year":"2004","unstructured":"S\u00f8rensen TL, Ransohoff R, Strieter R, Sellebjerg F (2004) Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. European journal of neurology 11:445\u2013449","journal-title":"European journal of neurology"},{"key":"648_CR179","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1468-1331.2001.00327.x","volume":"8","author":"TL S\u00f8rensen","year":"2001","unstructured":"S\u00f8rensen TL, Sellebjerg F, Jensen C, Strieter R, Ransohoff R (2001) Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. European journal of neurology 8:665\u2013672","journal-title":"European journal of neurology"},{"key":"648_CR180","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI5150","volume":"103","author":"TL S\u00f8rensen","year":"1999","unstructured":"S\u00f8rensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. The Journal of clinical investigation 103:807\u2013815","journal-title":"The Journal of clinical investigation"},{"key":"648_CR181","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0165-5728(02)00097-8","volume":"127","author":"TL S\u00f8rensen","year":"2002","unstructured":"S\u00f8rensen TL, Trebst C, Kivis\u00e4kk P, Klaege KL, Majmudar A, Ravid R, Lassmann H, Olsen DB, Strieter RM, Ransohoff RM (2002) Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. Journal of neuroimmunology 127:59\u201368","journal-title":"Journal of neuroimmunology"},{"key":"648_CR182","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","volume":"37","author":"SC Starossom","year":"2012","unstructured":"Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D (2012) Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37:249\u2013263","journal-title":"Immunity"},{"key":"648_CR183","doi-asserted-by":"crossref","unstructured":"Stilund, M., Gjelstrup, M. C., Petersen, T., M\u00f8ller, H. J., Rasmussen, P. V. & Christensen, T. 2015. Biomarkers of inflammation and axonal degeneration\/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF\/serum ratio to a biomarker panel. PloS one, 10.","DOI":"10.1371\/journal.pone.0119681"},{"key":"648_CR184","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4049\/jimmunol.1400825","volume":"193","author":"JS Stoolman","year":"2014","unstructured":"Stoolman JS, Duncker PC, Huber AK, Segal BM (2014) Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis. The Journal of Immunology 193:564\u2013570","journal-title":"The Journal of Immunology"},{"key":"648_CR185","first-page":"15","volume":"42","author":"A Szczucinski","year":"2004","unstructured":"Szczucinski A, Losy J (2004) Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosis. Folia neuropathologica 42:15\u201318","journal-title":"Folia neuropathologica"},{"key":"648_CR186","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/07315724.2017.1347074","volume":"36","author":"OR Tamtaji","year":"2017","unstructured":"Tamtaji OR, Kouchaki E, Salami M, Aghadavod E, Akbari E, Tajabadi-Ebrahimi M, Asemi Z (2017) The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Journal of the American College of Nutrition 36:660\u2013665","journal-title":"Journal of the American College of Nutrition"},{"key":"648_CR187","doi-asserted-by":"crossref","unstructured":"Tejera-Alhambra M, Casrouge A, De Andr\u00e9s C, Seyfferth A, Ramos-Medina R, Alonso B, Vega J, Fern\u00e1ndez-Paredes L, Albert ML, S\u00e1nchez-Ram\u00f3n S (2015) Plasma biomarkers discriminate clinical forms of multiple sclerosis. PLoS One, 10","DOI":"10.1371\/journal.pone.0128952"},{"key":"648_CR188","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.msard.2016.01.001","volume":"6","author":"J Topping","year":"2016","unstructured":"Topping J, Dobson R, Lapin S, Maslyanskiy A, Kropshofer H, Leppert D, Giovannoni G, Evdoshenko E (2016) The effects of intrathecal rituximab on biomarkers in multiple sclerosis. Multiple sclerosis and related disorders 6:49\u201353","journal-title":"Multiple sclerosis and related disorders"},{"key":"648_CR189","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0002-9440(10)63017-9","volume":"159","author":"C Trebst","year":"2001","unstructured":"Trebst C, S\u00f8rensen TL, Kivis\u00e4kk P, Cathcart MK, Hesselgesser J, Horuk R, Sellebjerg F, Lassmann H, Ransohoff RM (2001) CCR1+\/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. The American journal of pathology 159:1701\u20131710","journal-title":"The American journal of pathology"},{"key":"648_CR190","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.1523\/JNEUROSCI.2203-17.2018","volume":"38","author":"M Tsutsui","year":"2018","unstructured":"Tsutsui M, Hirase R, Miyamura S, Nagayasu K, Nakagawa T, Mori Y, Shirakawa H, Kaneko S (2018) TRPM2 exacerbates central nervous system inflammation in experimental autoimmune encephalomyelitis by increasing production of CXCL2 chemokines. Journal of Neuroscience 38:8484\u20138495","journal-title":"Journal of Neuroscience"},{"key":"648_CR191","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/gene.2012.55","volume":"14","author":"T Tuller","year":"2013","unstructured":"Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A (2013) Common and specific signatures of gene expression and protein\u2013protein interactions in autoimmune diseases. Genes & Immunity 14:67\u201382","journal-title":"Genes & Immunity"},{"key":"648_CR192","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2377-10-113","volume":"10","author":"A Uzawa","year":"2010","unstructured":"Uzawa A, Mori M, Hayakawa S, Masuda S, Nomura F, Kuwabara S (2010) Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica. BMC neurology 10:113","journal-title":"BMC neurology"},{"key":"648_CR193","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2010.06.007","volume":"137","author":"LM Villar","year":"2010","unstructured":"Villar LM, Espi\u00f1o M, Cavanillas ML, Rold\u00e1n E, Urcelay E, Emilio G, S\u00e1daba MC, Arroyo R, Gonz\u00e1lez-Porqu\u00e9 P, \u00c1lvarez-Cerme\u00f1o JC (2010) Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis. Clinical Immunology 137:51\u201359","journal-title":"Clinical Immunology"},{"key":"648_CR194","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.1047","volume":"63","author":"H Villarroya","year":"2001","unstructured":"Villarroya H, KLEIN C, Thillaye-Goldenberg B, Eclancher F (2001) Distribution in ocular structures and optic pathways of immunocompetent and glial cells in an experimental allergic encephalomyelitis (EAE) relapsing model. Journal of neuroscience research 63:525\u2013535","journal-title":"Journal of neuroscience research"},{"key":"648_CR195","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jneuroim.2006.03.018","volume":"176","author":"T Vyshkina","year":"2006","unstructured":"Vyshkina T, Kalman B (2006) Analyses of a MS-associated haplotype encompassing the CCL3 gene. Journal of neuroimmunology 176:216\u2013218","journal-title":"Journal of neuroimmunology"},{"key":"648_CR196","doi-asserted-by":"publisher","first-page":"e00648","DOI":"10.1002\/brb3.648","volume":"7","author":"S Wang","year":"2017","unstructured":"Wang S, Yang T, Wan J, Zhang Y, Fan Y (2017) Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission. Brain and behavior 7:e00648","journal-title":"Brain and behavior"},{"key":"648_CR197","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1242\/jcs.190702","volume":"129","author":"Y Wang","year":"2016","unstructured":"Wang Y, Cao Y, Mangalam AK, Guo Y, Lafrance-Corey RG, Gamez JD, Atanga PA, Clarkson BD, Zhang Y, Wang E (2016) Neuropilin-1 modulates interferon-\u03b3-stimulated signaling in brain microvascular endothelial cells. Journal of cell science 129:3911\u20133921","journal-title":"Journal of cell science"},{"key":"648_CR198","doi-asserted-by":"crossref","unstructured":"Wang Y, Jin S, Sonobe Y, Cheng Y, Horiuchi H, Parajuli B, Kawanokuchi J, Mizuno T, Takeuchi H, Suzumura A (2014) Interleukin-1\u03b2 induces blood\u2013brain barrier disruption by downregulating sonic hedgehog in astrocytes. PloS one, 9","DOI":"10.1371\/journal.pone.0110024"},{"key":"648_CR199","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1073\/pnas.86.2.612","volume":"86","author":"SD WOLPE","year":"1989","unstructured":"WOLPE SD, SHERRY B, JUERS D, DAVATELIS G, YURT RW, CERAMI A (1989) Identification and characterization of macrophage inflammatory protein 2. Proceedings of the National Academy of Sciences 86:612\u2013616","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"648_CR200","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11481-014-9553-1","volume":"9","author":"H Yi","year":"2014","unstructured":"Yi H, Bai Y, Zhu X, Zhao L, Wu X, Buch S, Wang L, Chao J, Yao H (2014) IL-17A induces MIP-1\u03b1 expression in primary astrocytes via Src\/MAPK\/PI3K\/NF-kB pathways: implications for multiple sclerosis. Journal of Neuroimmune Pharmacology 9:629\u2013641","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"648_CR201","doi-asserted-by":"publisher","first-page":"12396","DOI":"10.1523\/JNEUROSCI.3016-07.2007","volume":"27","author":"J Zhang","year":"2007","unstructured":"Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S (2007) Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. Journal of Neuroscience 27:12396\u201312406","journal-title":"Journal of Neuroscience"},{"key":"648_CR202","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.10.001","volume":"240","author":"X Zhong","year":"2011","unstructured":"Zhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X (2011) Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica. Journal of neuroimmunology 240:104\u2013108","journal-title":"Journal of neuroimmunology"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00648-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-020-00648-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00648-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T23:26:49Z","timestamp":1724282809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-020-00648-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":202,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00648-6","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}